Indivior Share Price | |
---|---|
Price | 1,520.00 |
Bid | 0.00 |
Ask | 0.00 |
Change | 0.00 (0.00%) |
Volume | 0 |
Open | 0.00 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 1,520.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 135.51m |
Market Capitalisation | £2.06b |
Market Size | 1,500 |
52 Week High | 1,927.00 |
52 Week High Date | 27-Jul-2023 |
52 Week Low | 1,128.00 |
52 Week Low Date | 19-Dec-2023 |
# Trades | 0 |
---|---|
Vol. Sold | 0 |
Sold Value | £N/A |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | 1,935.25552 |
Earnings | 0.785426 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
23-Apr-24 | 18:08:47 | 1,500.258 | 3,411 | Unknown* | 1,509.00 | 1,511.00 | 51.17k | O Ordinary Was reported as OTC |
23-Apr-24 | 18:07:14 | 1,499.105 | 5,824 | Unknown* | 1,509.00 | 1,511.00 | 87.31k | O Ordinary Was reported as OTC |
23-Apr-24 | 17:50:16 | 1,520.00 | 1,008 | Unknown* | 1,509.00 | 1,511.00 | 15.32k | O Ordinary Was reported as OTC |
23-Apr-24 | 17:50:03 | 1,504.00 | 1,414 | Unknown* | 1,509.00 | 1,511.00 | 21.27k | O Ordinary Was reported as OTC |
23-Apr-24 | 17:47:32 | 1,505.498 | 6,909 | Unknown* | 1,509.00 | 1,511.00 | 104.01k | O Ordinary Was reported as OTC |
23-Apr-24 | 17:44:51 | 1,495.65 | 23 | Unknown* | 1,509.00 | 1,511.00 | 344.00 | O Ordinary Was reported as OTC |
23-Apr-24 | 17:44:51 | 1,494.649 | 34 | Unknown* | 1,509.00 | 1,511.00 | 508.18 | O Ordinary Was reported as OTC |
23-Apr-24 | 17:36:19 | 1,503.897 | 871 | Unknown* | 1,509.00 | 1,511.00 | 13.10k | O Ordinary Was reported as OTC |
23-Apr-24 | 17:36:19 | 1,501.985 | 19 | Unknown* | 1,509.00 | 1,511.00 | 285.38 | O Ordinary Was reported as OTC |
23-Apr-24 | 17:27:22 | 1,495.524 | 659 | Unknown* | 1,509.00 | 1,511.00 | 9,856 | O Ordinary Was reported as OTC |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
18-Mar-24 | 15-Mar-24 | Transfer From | Ryan Preblick held the position of CFO & Executive Director at the time of this trade.Ryan Preblick | 0.00 | 3,920 | 229,089 | |
18-Mar-24 | 18-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,617.00 | GBX | 10,549 | 335,935 |
18-Mar-24 | 15-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,644.00 | GBX | 15,444 | 335,935 |
18-Mar-24 | 14-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,630.00 | GBX | 91,204 | 335,935 |
18-Mar-24 | 15-Mar-24 | Exercise of Option | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 555.00 | GBX | 15,444 | 335,935 |
Indivior is working to change patients lives by developing medicines to treat addiction and serious mental illnesses.